Vazyme(SH:688105)2023-10-27 16:00Financial Performance - The company's operating revenue for the current reporting period decreased by 56.48% compared to the previous period, primarily due to a significant decline in COVID-19 testing-related services[13] - The net profit attributable to shareholders of the listed company for the current reporting period decreased by 96.54%, mainly due to the decrease in revenue scale[13] - The net cash flow from operating activities for the year-to-date period decreased by 114.54%, primarily due to reduced cash inflow from operations[13] - Total operating revenue for the first three quarters of 2023 was CNY 869,295,118, a significant decrease from CNY 2,305,008,853 in the same period of 2022, representing a decline of approximately 62.2%[30] - The net profit for the third quarter of 2023 was a loss of CNY 77,716,085.16, compared to a net profit of CNY 749,497,519.33 in the same quarter of 2022, reflecting a significant downturn[38] - The company's total equity decreased to CNY 4,017,617,718.95 as of September 30, 2023, down from CNY 4,612,108,180.66 at the end of 2022, representing a decline of approximately 12.9%[30] - The total comprehensive income attributable to the parent company was -79,503,851.59 CNY, compared to 749,735,147.00 CNY in the previous year[40] - Basic and diluted earnings per share were both -0.19 CNY, down from 1.87 CNY in the same period last year[40] Cash Flow and Investments - The net cash flow from operating activities was -18,594,982.41 CNY, a significant decrease from 127,862,604.78 CNY in the previous year[44] - Cash inflow from investment activities totaled 3,415,829,373.96 CNY, down from 6,844,493,668.60 CNY year-over-year[44] - Net cash flow from investment activities was -909,425,832.95 CNY, compared to -729,948,885.55 CNY in the previous year[44] - Cash inflow from financing activities was 1,387,800,000.00 CNY, significantly higher than 300,000,000.00 CNY in the previous year[44] - The ending cash and cash equivalents balance was 827,363,105.30 CNY, down from 953,481,183.60 CNY at the end of the previous year[46] - The company reported a decrease in cash received from sales of goods and services, totaling 1,277,346,901.36 CNY compared to 2,092,949,566.64 CNY in the previous year[40] Research and Development - Research and development expenses for the current reporting period decreased by 34.05%, reflecting a focus on improving R&D efficiency and resource utilization[14] - Research and development expenses for the third quarter of 2023 were CNY 246,376,539.96, a decrease from CNY 269,896,412.14 in the same quarter of 2022, indicating a reduction of about 8.7%[34] - R&D expenses totaled ¥74,489,633.30 in Q3 2023, a decrease of 34.05% year-over-year, while R&D investment as a percentage of revenue increased to 24.97%[54] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,891[14] - The largest shareholder, Nanjing Nuoyizan Investment Management Co., Ltd., holds 40.48% of the shares[14] - The company has not identified any related party transactions among the top ten shareholders[16] Assets and Liabilities - As of September 30, 2023, total assets amounted to RMB 5,712,139,569.82, while total liabilities were RMB 1,529,353,902.10[28] - The company's total liabilities as of September 30, 2023, amounted to CNY 1,694,521,850.87, an increase from CNY 1,393,103,573.85 at the end of 2022, marking a rise of approximately 21.7%[30] - The company's non-current assets totaled RMB 1,498,458,894.98, compared to RMB 1,440,102,266.63 in the previous period[28] - The company reported a significant increase in fixed assets, rising to RMB 478,520,111.80 from RMB 411,468,346.61[28] - The total assets as of September 30, 2023, were CNY 5,712,139,569.82, down from CNY 6,005,211,754.51 at the end of 2022, reflecting a decrease of approximately 4.9%[30] - The total equity attributable to shareholders decreased to ¥4,017,146,301.43, a decline of 12.84% compared to the previous year[54] Corporate Actions - The company established a wholly-owned subsidiary in South Korea with a registered capital of 10,000 million KRW, holding a 100% stake[19] - A wholly-owned subsidiary was established in Hungary with a registered capital of 2,000 million HUF, also holding a 100% stake[20] - The company set up a wholly-owned subsidiary in Guangzhou with a registered capital of 1,000,000 RMB, maintaining a 100% ownership[20] - The company is actively progressing with the implementation of the 2023 restricted stock incentive plan[19] Financial Statements - The financial statements for the third quarter were not audited[8]